Search Within

Adult Leukemia

Formats
  1. Meeting Abstract (1797)
  2. Journal Article (1603)
  3. Review (122)
  4. Research Letter (55)
  5. Editorial (49)
  6. Book Section (39)
  7. Guidelines (20)
  8. Conference Paper (18)
  9. Correspondence (13)
  10. Miscellaneous (3)
  11. Book Whole (1)
Groups
  1. Center for Hematologic Malignancies (3720)
  2. Department of Medicine (3689)
  3. Hematologic Malignancies, Division of (3685)
  4. GSK Faculty (1783)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (1378)
  6. Executive Committee, Center for Hematologic Malignancies (970)

More Groups

People
  1. Ross Levine (787)
  2. Martin Tallman (655)
  3. David Scheinberg (502)
  4. Jae Park (387)
  5. Eytan Stein (371)
  6. Raajit Rampal (352)

More People

Years
  1. 2025 (103)
  2. 2024 (196)
  3. 2023 (233)
  4. 2022 (255)
  5. 2021 (248)
  6. 2020 (273)

More Years

Publications
  1. Blood (1254)
  2. Journal of Clinical Oncology (217)
  3. Clinical Lymphoma, Myeloma and Leukemia (117)
  4. Leukemia (110)
  5. Haematologica (107)
  6. Cancer Research (86)

More Publications

Publishers
  1. American Society of Hematology (1345)
  2. Nature Publishing Group (324)
  3. Elsevier Inc. (255)
  4. American Association for Cancer Research (234)
  5. American Society of Clinical Oncology (230)
  6. Ferrata Storti Foundation (107)

More Publishers

Results (3720)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Astarabine, a novel leukemia-targeted cytarabine composition allows, for the first time, the delivery of high cytarabine doses for older or unfit patients with acute leukemia. Results of an ongoing phase I/IIa study
    Meeting Abstract

    Zuckerman, T.; Gengrinovitch, S.; Ben-Yakar, R.; Hoffman, R.; Henig, I.; Lavi, N.; Akria, L.; Ofran, Y.; Horowitz, N. A.; Nudelman, O.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Treatment-free remission (TFR) in patients with chronic phase chronic myeloid leukemia (CML-CP) and in stable deep molecular response (DMR) to dasatinib - The DASFREE study
    Meeting Abstract

    Shah, N. P.; Paquette, R.; Müller, M. C.; Saussele, S.; Garcìa-Gutiérrez, V.; Jiménez-Velasco, A.; Nicolini, F. E.; Mauro, M. J.; Mahon, F. X.; Rea, D.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Real-world treatment patterns, healthcare resource utilization, and costs in patients with newly diagnosed acute myeloid leukemia (AML)
    Meeting Abstract

    Stein, E. M.; Latremouille-Viau, D.; Guerin, A.; Shi, S.; Gagnon-Sanschagrin, P.; Bonifacio, G.; Joseph, G. J.
    Blood (2016)

    Fulltext@MSK | Save
  • A phase I dose finding trial of eltrombopag during consolidation therapy in adults with acute myeloid leukemia employing a unique dosing design: PrE0901, a PrECOG Study
    Meeting Abstract

    Strickland, S. A.; Lazarus, H. M.; Wang, X. V.; Cerny, J.; Rybka, W. B.; Tallman, M. S.; Litzow, M. R.
    Blood (2016)

    Fulltext@MSK | Save
  • Long-term safety experience with arsenic trioxide in patients with acute promyelocytic leukemia
    Meeting Abstract

    Tallman, M. S.; Lo-Coco, F.; Pathak, A.
    Blood (2016)

    Fulltext@MSK | Save
  • ENESTgoal treatment-free remission study: Updated preliminary results and digital polymerase chain reaction analysis in patients with chronic myeloid leukemia in chronic phase who switched from imatinib to nilotinib
    Meeting Abstract

    Ritchie, E. K.; Catchatourian, R.; Klisovic, R. B.; Pinilla-Ibarz, J.; Deininger, M. W.; Erba, H. P.; Radich, J. P.; Savona, M. R.; Dautaj, I.; Wolff, J.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Hypermethylation of GADD45A defines a methylation profile distinct to mutant IDH1/2, and correlates with more aggressive AML
    Meeting Abstract

    Samaraweera, S. E.; Garrett-Bakelman, F. E.; Neelamraju, Y.; Perugini, M.; Casolari, D. A.; Iarossi, D.; Bray, S. C.; Sheridan, C.; Lee, T. C.; Tiong, I. S.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • CD33-directed chimeric antigen receptor (CAR) T cells for the treatment of acute myeloid leukemia (AML)
    Meeting Abstract

    Rafiq, S.; Purdon, T. J.; Schultz, L. M.; Brentjens, R. J.
    Blood (2016)

    Fulltext@MSK | Save
  • Impact of genomic alterations on outcomes in myelofibrosis patients undergoing allogeneic hematopoietic stem cell transplantation
    Meeting Abstract

    Rampal, R. K.; Tamari, R.; Zhang, N.; McNamara, C. J.; Rapaport, F.; Litvin, R.; Maloy, M. A.; Castro-Malaspina, H.; Giralt, S.; Weinberg, R. S.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • A pediatric-inspired regimen containing multiple doses of intravenous pegylated asparaginase appears safe and effective in newly diagnosed adult patients with Ph-negative acute lymphoblastic leukemia in adults up to age 60: Results of a multi-center phase II clinical trial
    Meeting Abstract

    Park, J. H.; Ritchie, E. K.; Rao, A. V.; Devlin, S.; Hsu, M.; Khawaja, T. T.; O'Donnell, B. A.; Cazacu, M. I.; Stopka, D. M.; Tallman, M. S.; more...
    Blood (2016)

    Fulltext@MSK | Save